VeriMomkojic dipalmitate hamilelikte güvenli mi?
No harmonised reproductive classification was found for kojic dipalmitate and no peer‑reviewed evidence shows reproductive or teratogenic effects for the dipalmitate; the Cosmetic Ingredient Review concluded kojic acid (the parent) was not a reproductive toxicant and was safe at typical cosmetic use levels. Skin‑permeation work on formulations containing kojic dipalmitate shows measurable dermal penetration, so low but measurable systemic exposure is plausible. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/21164073/))
Pregnancy-safe products containing kojic dipalmitate
Related ingredients
Frequently asked questions
- kojic dipalmitate hamilelikte güvenli mi?
- No harmonised reproductive classification was found for kojic dipalmitate and no peer‑reviewed evidence shows reproductive or teratogenic effects for the dipalmitate; the Cosmetic Ingredient Review concluded kojic acid (the parent) was not a reproductive toxicant and was safe at typical cosmetic use levels. Skin‑permeation work on formulations containing kojic dipalmitate shows measurable dermal penetration, so low but measurable systemic exposure is plausible. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/21164073/))
- kojic dipalmitate emzirirken güvenli mi?
- No data indicate reproductive toxicity or lactation/breastfeeding hazards for kojic dipalmitate; parental kojic acid was not found to be a reproductive toxicant in the CIR review. Because dermal absorption of dipalmitate/derived kojic acid is low but measurable in some formulations, low systemic exposure (and therefore potential minimal transfer to breastmilk) cannot be excluded but there is no direct evidence of harm. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/21164073/))
- kojic dipalmitate bebek cildi için güvenli mi?
- No infant‑specific reproductive/developmental hazard data were identified for kojic dipalmitate. Given measurable dermal uptake in some formulations in adults, the exposure score for infants is increased by +1 (immature barrier and higher surface‑area‑to‑weight). There is no evidence that baby skin exposure causes developmental toxicity, but infant dermal exposure is plausibly higher than adult for ingredients with measurable absorption. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9959276/?utm_source=openai))
- VeriMom kojic dipalmitate nasıl puanlıyor?
- VeriMom kojic dipalmitate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte kojic dipalmitate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.